![]() |
市場調查報告書
商品編碼
1986783
麻醉用二氧化碳吸收劑市場報告:按產品、類型、最終用戶和地區分類(2026-2034 年)Anesthesia CO2 Absorbent Market Report by Product (Soda Lime, Medisorb, Dragersorb, Amsorb, Litholyme, and Others), Type (Premium, Traditional), End User (Hospitals, Clinics, and Others), and Region 2026-2034 |
||||||
2025年,全球麻醉用二氧化碳吸收劑市場規模達8,740萬美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到1.368億美元,2026年至2034年的複合年成長率(CAGR)為4.96%。醫院和診所手術量的不斷增加推動了對可靠吸收劑的需求,從而促進了市場成長。
對環保解決方案的需求日益成長
隨著環境問題的日益關注,醫療專業人員越來越傾向於選擇能夠最大限度地減少有害副作用的二氧化碳吸收劑。此外,環保吸收劑能夠降低麻醉程序對環境的影響,並與醫院的永續性目標相契合,從而推廣安全有效的替代方案,在確保有效患者照護的同時,為營造更健康的環境做出貢獻。例如,根據貝爾醫療公司(Bell Medical Inc.)2024年5月發表的報導,不含氫氧化鈉的「amsorb plus」二氧化碳吸收劑透過防止有害副產物的產生並實現低新鮮氣體流量,從而促進了環境友善麻醉。這不僅減少了麻醉劑污染,提高了永續性,也擴大了麻醉用二氧化碳吸收劑的市場規模。
低流量麻醉技術的進展
向低流量麻醉技術的轉變能夠改善患者預後並減少氣體浪費。此外,支援這些技術的二氧化碳吸收器創新使醫生能夠在較低的新鮮氣體流量下維持有效的通氣,從而最佳化資源利用並確保手術環境中的高效氣體管理。例如,2024年8月,Penlon推出了配備吸收器和二氧化碳監測功能的E-Flo 6C麻醉機。這透過先進的通氣控制和全面的氣體監測系統,提高了低流量麻醉的安全性和精確性。根據麻醉二氧化碳吸收器的市場細分,這是一個重要的成長促進因素。
改進二氧化碳吸收系統的整合
麻醉機二氧化碳吸收功能的日益整合簡化了操作,並減少了組件間的多重連接。因此,組裝更快,使用更方便。這使得麻醉程序的管理更加高效,同時確保最佳的二氧化碳吸收性能,尤其是在關鍵的麻醉環境中。例如,飛利浦於2024年10月推出了Siesta i Whispa麻醉機,這是一款整合式呼吸系統(IBS),配備上升式氣囊和二氧化碳吸收器。這款創新產品簡化了設備與患者的連接,縮短了設定時間,並提高了清潔效率。
The global anesthesia CO2 absorbent market size reached USD 87.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 136.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.96% during 2026-2034. The increasing number of surgeries across hospitals and clinics is raising the demand for reliable absorbents, which is stimulating the market.
Growing Demand for Eco-Friendly Solutions
Healthcare providers are increasingly seeking CO2 absorbents that minimize harmful side effects, as environmental concerns are growing. In addition, eco-friendly absorbents reduce the ecological footprint of anesthesia practices and align with sustainability initiatives within hospitals, thereby promoting safer alternatives that contribute to a healthier environment while maintaining effective patient care. For instance, in May 2024, according to an article published by Bell Medical Inc., the sodium hydroxide-free amsorb plus CO2 absorbent is promoting eco-friendly anesthesia by preventing harmful byproducts, and enabling low fresh gas flow techniques, thereby reducing anesthetic agent pollution, improving sustainability, and elevating anesthesia CO2 absorbent market scope.
Advancements in Low-Flow Anesthesia Technologies
The rising shift towards low-flow anesthesia techniques enhances patient outcomes and reduces wasteful gas usage. Moreover, innovations in CO2 absorbents that support these technologies facilitate doctors to maintain effective ventilation with lower fresh gas flows, thereby optimizing resource utilization and ensuring efficient gas management in surgical environments. For instance, in August 2024, Penlon launched the E-Flo 6C anesthesia machine, featuring absorber and CO2 monitoring, thereby enhancing safety and precision in low-flow anesthesia through advanced ventilation control and comprehensive gas monitoring systems. As per the anesthesia CO2 absorbent market segmentation, this is acting as a significant growth-inducing factor.
Improved Integration of CO2 Absorption Systems
Enhanced integration of CO2 absorption within anesthesia machines simplifies the operational setup, reducing the need for multiple connections between components. In contrast, this leads to faster assembly and improved usability, making it simpler to manage anesthesia procedures efficiently while ensuring optimal CO2 absorption performance, particularly in critical anesthesia environments. For instance, in October 2024, Philips introduced the Siesta i Whispa anesthesia machine, an integrated breathing system (IBS) with an ascending bag-in-bottle and CO2 absorber. This innovation streamlines connections between the machine and patient, reducing setup time and improving cleaning efficiency.
Medisorb currently hold the largest anesthesia CO2 absorbent market share
Medisorb exhibits a clear dominance in the market due to its efficient CO2 absorption capabilities, which enhance patient safety during procedures. For example, Medisorb EF was launched to minimize compound formation, thereby ensuring better anesthesia care while reducing environmental impact in medical settings.
Premium currently holds the largest anesthesia CO2 absorbent market demand
The premium segment dominates the market due to its high efficiency, longer-lasting performance, and superior safety features. For example, Drager launched its premium product 'Dragersorb' with enhanced CO2 absorption capabilities, which reduces the risk of compound A formation, ensuring patient safety during anesthesia procedures.
Hospital exhibits the largest anesthesia CO2 absorbent market outlook
Hospitals lead the market as the primary end users, driven by the need for efficient patient care during surgeries. For example, GE Healthcare launched Aisys CS2, an advanced anesthesia machine incorporating CO2 absorbents to enhance safety and reduce environmental impact.
North America currently dominates the market
The anesthesia CO2 absorbent market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the anesthesia CO2 absorbent market overview, North America dominates the market, which is driven by well-established healthcare systems, high surgical volumes, and innovative advancements. In addition, the region's dominance is also supported by growing awareness of patient safety and effective waste gas management during surgeries. For example, Drager launched its 'Dragersorb Free' absorbent, a CO2 absorbent designed to prevent the formation of toxic compounds during anesthesia. Furthermore, such innovations highlight North America's role in advancing safe and efficient anesthesia practices.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all market companies have also been provided. Some of the key players in the market include:
()